The pharmaceutical chemicals market has seen considerable growth due to a variety of factors.
• The size of the pharmaceutical chemicals market has seen a significant expansion in past years. The market, which is expected to rise from $138.71 billion in 2024 to $148.39 billion in 2025, is projected to have a compound annual growth rate (CAGR) of 7.0%.
The upgrade in the historic phase can be connected to developments in drug innovation, an increase in the elderly population, alterations in regulations, and the escalation of chronic diseases.
The pharmaceutical chemicals market is expected to maintain its strong growth trajectory in upcoming years.
• In the coming years, the pharmaceutical chemicals market is anticipated to witness robust expansion. The market is predicted to escalate to a value of $197.77 billion in 2029, with a compound annual growth rate (CAGR) of 7.4%.
The anticipated growth in this period can be ascribed to factors such as personalized medicine, biopharmaceuticals and biosimilars, developing markets, digital health, and telemedicine. Notable trends for the forecast period are precision drug manufacturing, gene and cell therapies, drug repurposing, as well as vaccine development and production.
The rising incidence of neurological disorders is likely to catalyze the expansion of the pharmaceutical chemicals market. Neurological disorders, affecting the central and peripheral nervous system - inclusive of the brain, spinal cord, and body-wide nerves, have seen an upswing. The chemicals from the pharmaceutical industry aid in crafting drugs explicit to these disorders, mitigating pain and movement abnormalities. Particularly, the Alzheimer's Disease Facts and Figures report of 2023 by Alzheimer's Association, a health organization from the US offering Alzheimer's specific care, has conveyed that around 6 million of its citizens were battling Alzheimer's in 2023, a figure projected to grow to nearly 13 million by 2030. Additionaly, the national cost for Alzheimer's and other dementia-related conditions are prophesied to reach an overwhelming $1 trillion by 2050, up from $345 billion in 2023. This surge in neurological disorder prevalence, consequently, fuels the pharmaceutical chemicals market. The swelling of the pharmaceutical sector is anticipated to impel the pharmaceutical chemicals market's growth in the forthcoming years. This industry is characterized by researching, developing, and producing pharmaceuticals and medications. The chemicals procured from the pharmaceutical industry serve in many capacities such as solvents, reagents, catalysts, active elements, and excipients, and are indispensable in manufacturing various pharmaceutical products like medicine, ointments, vaccines, dietary aids, and infant milk formulas. Specifically, data from the European Federation of Pharmaceutical Industries and Associations (EFPIA), a Belgium-based association representing the pharmaceutical industry, showed that the total pharmaceutical production in Europe, at $368,832 million (€340,000 million) in 2022, saw an approximate increment of 4.95% from the $351,420 million (€323,950 million) in 2021. Thus, the expansion of the pharmaceutical industry has become a driving force for the pharmaceutical chemicals market.
The pharmaceutical chemicals market covered in this report is segmented –
1) By Product Type: Solvents, Reagents Or Catalysts, KSMs Or Intermediates, Building Blocks For APIs Or Advanced Intermediates
2) By Drug Type: Proprietary, Non-Proprietary
3) By Application: Cardiovascular Disease, Neurological Disease, Oncological Disease, Respiratory Disease, Gastrointestinal Disease, Musculoskeletal Disease
Subsegments:
1) By Solvents: Organic Solvents, Inorganic Solvents, Aqueous Solvents
2) By Reagents or Catalysts: Organic Reagents, Inorganic Reagents, Biocatalysts
3) By KSMs or Intermediates: Key Starting Materials (KSMs), Pharmaceutical Intermediates
4) By Building Blocks for APIs or Advanced Intermediates: Simple Building Blocks, Complex Building Blocks
Technological advancements, particularly in software-as-a-service (SaaS) quantum chemistry platforms, are being adopted by significant pharmaceutical chemical companies to retain their market dominance. These SaaS quantum chemistry platforms are cloud-based services that provide access to quantum chemistry software and resources on a subscription basis. For example, QC Ware Corp, an American quantum computing software firm, introduced Promethium, a SaaS quantum chemistry platform, in April 2023. This innovative platform is specially crafted to expedite the discovery of pharmaceuticals, chemicals, and materials through an advanced quantum chemistry toolkit leveraging H100 or A100 Tensor Core. The Promethium toolkit allows for swift calculations of various chemical systems comprising approximately 100 atoms in a few seconds, a task which would take minutes or hours using conventional algorithms.
Major companies operating in the pharmaceutical chemicals market are:
• BASF SE
• The Dow Chemical Company
• Abbott Laboratories
• Johnson Matthey PLC
• Evonik Industries AG
• Eastman Chemical Company
• Koninklijke DSM N.V
• Lanxess AG
• Albemarle Corporation
• Lonza Group AG
• Clariant AG
• W. R. Grace and Co
• Jubilant Life Sciences Ltd.
• Sumitomo Seika Chemicals Co Ltd.
• Borregaard ASA
• WeylChem International GmbH
• Vertellus Holdings LLC
• CABB Group GmbH
• Dishman Carbogen Amcis Ltd.
• Hikal Ltd.
• Porton Fine Chemicals Ltd.
• Denisco Chemicals Pvt Ltd.
• CHEMADA Industries Ltd.
• Valaji Pharma Chem
• Syntor Fine Chemicals Ltd.
• Kenko Corporation.
North America was the largest region in the pharmaceutical chemicals market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pharmaceutical chemicals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.